PBL fights on in AFT Pascomer battle

PBL fights on in AFT Pascomer battle
The court allowed PBL a 35% share of all future profits from Pascomer sales.(Image: Unsplash)
Staff reporters
PBL Solutions is appealing part of a high court judgment that found substantially in its favour in its stoush with AFT Pharmaceuticals over the so-called “orphan” (commercially undeveloped) drug Pascomer.The court found in favour of PBL, which is a 35% shareholder in AFT Orphan Pharmaceuticals (AFTO), in relation to its claim that AFT should have given AFTO the opportunity to pursue the development of the orphan drug Pascomer.Instead, AFT developed the drug on its own behalf. PBL claimed it had done the work to identify the com...